Investment Areas

Codon Capital’s focus is in two biology disciplines, Therapeutics and Synthetic Biology, each with unique investment benefits. Together, they represent the new “biology design revolution,” opportunities that will define healthcare, agriculture, and more during this decade.

Therapeutics

Our Therapeutics investments are sourced to meet the following criteria:
  • Novel technology approaches
  • Ability to dramatically modify a disease
  • Keen flexibility to change and adapt
  • Value as a pre-clinical acquisition or an IPO
  • Spin-off assets from existing companies

Synthetic Biology

Attractive Synthetic Biology opportunities:
  • New types of therapeutics
  • Technology that disrupts at over 20x
  • Should deliver better, faster and cheaper
  • Companies that accelerate the biotransformation of existing industries
  • Emerging but important investment frontier that's unlikely to generate exits at a Series A
© 2019-2020 Content: Codon Capital.  Artwork: Creative Market.                                                       Codon Capital | BioTech Venture Investment | San Francisco